The treatment of large tumors such as sarcomas with intra-operative radiotherapy using a Mobetron R is often complicated because of the limited field size of the primary collimator and the available applicators (max Ø100 mm). To circumvent this limitation a prototype rectangular applicator of 80 × 150 mm 2 was designed and built featuring an additional scattering foil located at the top of the applicator. Because of its proven accuracy in modeling linear accelerator components the design was based on the EGSnrc Monte Carlo simulation code BEAMnrc. First, the Mobetron R treatment head was simulated both without an applicator and with a standard 100 mm applicator. Next, this model was used to design an applicator foil consisting of a rectangular Al base plate covering the whole beam and a pyramid of four stacked cylindrical slabs of different diameters centered on top of it. This foil was mounted on top of a plain rectangular Al tube. A prototype was built and tested with diode dosimetry in a water tank. Here, the prototype showed clinically acceptable 80 × 150 mm 2 dose distributions for 4 MeV, 6 MeV and 9 MeV, obviating the use of complicated multiple irradiations with abutting field techniques. In addition, the measurements agreed well with the MC simulations, typically within 2%/1 mm.
Introduction
Intra-operative electron radiotherapy (IORT) plays an important role in the treatment of advanced rectal and gynecological cancer (Garton et al 1997 , Krempien et al 2006b , Roeder et al 2007 , Tran et al 2007 . Its value as an alternative for external treatment of breast cancer is being investigated (Reitsamera et al 2002 , Cuncins-Hearn et al 2004 , Veronesi et al 2005 , Lemanski et al 2006 . IORT can be performed using a conventional linear accelerator (linac), either by turning a regular treatment vault into an operating room or vice versa. In recent years small mobile linacs with limited energy, limited field size, no bending magnet and a beam stopper have become available on the market. The design of these linacs is optimized for minimal radiation leakage allowing them to be operated in an unmodified operation room with only minimal radiation safety measures such as restriction on the yearly given number of monitor units (MU). This paper focuses on one of these linacs, the Mobetron R (Intraop Medical Corporation, Sunnyvale, CA). The Mobetron R has four beam energies of 4 MeV, 6 MeV, 9 MeV and 12 MeV. Applicators are cylindrical tubes with a length of 300 mm and diameters ranging from 30 mm to 100 mm. The maximum field size is limited to 100 mm at the distal end of the applicator (547 mm nominal SSD) by the fixed primary collimator. Figure 1 shows how the use of for instance a 150 mm applicator would result in clinically unacceptable beam profiles. While most IORT-procedures are not limited by the maximum field size, the treatment of certain lesions such as sarcomas often requires larger field sizes (Oertel et al 2006 , Krempien et al 2006a . To circumvent multiple irradiations with abutting field techniques (McKenzie 1998 , Beddar et al 2006 a large field size applicator is desirable.
The aim of this study was to develop the means to treat a large 80 × 150 mm 2 area with a single applicator using the Mobetron R . The approach was to employ an additional scattering foil on top of a rectangular applicator. The design goals were: (1) field flatness comparable to the standard 100 mm diameter applicator, (2) minimal loss in penetration depth (R 90 up to 2.5 cm is desirable), (3) limited increase of bremsstrahlung contamination and (4) no decrease in entrance dose, and finally (5) a dose rate of at least 0.5 cGy MU −1 (∼500 cGy min −1 ), which is half of the dose rate for the standard 100 mm diameter applicator.
Materials and methods
The design of the rectangular applicator and the applicator foil is based on Monte Carlo (MC) simulations. This method has proven accuracy in simulating treatment head components and dose distributions (see, for example, Ma and Jiang (1999) ). Here, the design process was subdivided into two phases. First, the treatment head of the Mobetron R was modeled and next the resulting model was used to determine the properties of the rectangular applicator with add-on applicator foil. In both phases the MC results were tested with experimental data.
Monte Carlo modeling the Mobetron R treatment head
The goal of the first phase was to model the treatment head of the Mobetron R so that both simulated percentage depth dose (PDD) curves and simulated beam profiles matched with measurements to 2%/1 mm in two configurations: (1) a Mobetron R with a 100 mm applicator and (2) a Mobetron R without an applicator. This study uses the EGSnrc system (Kawrakow 2000) , version 1.11 of May 16, 2002, for MC simulation with the user codes BEAMnrc (Rogers et al 1995) , version 1.78 of January 12, 2004, and a modified version of MCRTP (Faddegon et al 1998) , version 2.0 of January 4, 2006, to work with EGSnrc. A drawing of the model used to simulate the Mobetron R is shown in figure 2 . The model consists of a source, exit window, primary collimator, primary scattering foil, secondary scattering foil, dose chamber and applicator (optional).
The source parameters (intensity distribution, angular spread and energy distribution) of the model were revised until a good match with measured data was achieved. This resulted in a source with a Gaussian distributed intensity profile of 1 mm full-width-half-maximum (FWHM). The Mobetron R does not have a bending magnet for energy selection. Consequently the angular and energy distribution of the source could be quite large. However, BEAMnrc does not feature the use of angular spread in combination with a Gaussian distributed intensity profile. In addition, a sensitivity analysis showed that the introduction of angular spread up to 5
• had only little (2-3%) to no effect-varying the source size from 0.1 mm to 4 mm FWHM showed effects larger than 10%-on the off-axis ratio of the open field. Therefore, we chose to simulate the beam with normal incidence on the exit window. In a similar analysis Björk et al (2002) demonstrated that the dose distribution of a 12 MeV electron beam (Elekta SL25) is insensitive to both angular spread and source size. However, they point out that a different design of the scattering foil system could influence the importance of these parameters as we have found here by varying the source size for the Mobetron R . The mean value and FWHM of the Gaussian-shaped energy distributions were determined from matching the percentage depth dose (PDD) curves. This resulted in 4.4 MeV (10% FWHM), 6.3 MeV (25% FWHM), 9.6 MeV (20% FWHM) and 13.0 MeV (20% FWHM) energy distributions for the nominal energies of the Mobetron R : 4 MeV, 6 MeV, 9 MeV and 12 MeV, respectively. While the FWHMs were assessed from the shape of the PDDs, the mean energies were derived from the depth of the 50% dose levels (R 50 ) using a linear fit (correlation coefficient R 2 = 0.99998) from the sensitivity analysis data
Geometrical dimensions of the primary and secondary scattering foils were also varied in a sensitivity analysis. Here, variations of 10% in thickness and relative spacing showed only little (2-3%) to no effect on the off-axis ratio. It was therefore decided not to adjust the manufacturers' geometrical specifications for the final model. In addition, our findings are in agreement with those reported by Bieda et al (2001) for low energy (6 MeV and 12 MeV) electron beams (Varian Clinac 2100C).
To maintain comparable statistics in the resulting dose distributions 75, 37.5, 25 and 20 million electrons were simulated for the 4 MeV, 6 MeV, 9 MeV and 12 MeV beams respectively. No variance reduction techniques were used. Transport parameters included electron lower energy cut-offs ECUT and AE of 0.7 MeV and photon lower energy cut-offs PCUT and AP of 1 keV. Other parameters included a maximum step size SMAX of 5 cm, ESTEPE of 0.25, XIMAX of 0.5, skin depth for BCA defaulted, spin effect on, bremsstrahlung angular sampling and pair angular sampling both simple, and bremsstrahlung cross-section Bethe-Heitler. Bound Compton scattering, Rayleigh scattering, atomic relaxations and photoelectron angular sampling were all turned off.
For each BEAMnrc run, information about each particle that traversed the user-defined scoring planes was written in phase-space files. The locations of the two scoring planes that were used in this study are shown in figure 2. The first scoring plane was defined at the bottom of the primary collimator and the second scoring plane was defined at the bottom of the applicator. The phase-space files were then used as input for MCRTP to calculate threedimensional dose distributions in a virtual water phantom with dimensions of 300 × 300 × 70 mm 3 and a voxel size of 2 × 2 × 2 mm 3 . The location of the water surface was defined at a fixed distance of 341 mm from the bottom of the primary collimator: a Mobetron R applicator (300 mm) is positioned 40 mm from the primary collimator. For measurement purposes, an additional air gap of 1 mm was used between the bottom of the applicator and the water surface, giving a source-to-surface distance (SSD) of 548 ± 2 mm. In the case of the configuration without an applicator, the same SSD was maintained. The PDDs were determined at the central axis, while the beam profiles along the main axes were determined both at a depth of 5 mm and at the nominal depth of the dose maximum d max , which we estimated at 9 mm, 13 mm, 19 mm and 17 mm for 4 MeV, 6 MeV, 9 MeV and 12 MeV respectively. To improve statistics the PDDs were determined from the average over an area of 10 × 10 bins; the beam profiles were determined from the average over three bins (6 mm) in the beam direction and over five bins (10 mm) in the transversal beam direction. An analysis of the dose distributions showed these bins sizes had minimal effect on the shapes of the profiles. Finally, the systems' cylindrical symmetry was exploited by averaging the profiles about both the positive and the negative x-and y-axes resulting in one single-sided beam profile.
Measurements were performed at the Catharina-hospital, Eindhoven (CZE). A Scanditronix EFD 3G diode was used in a water tank at a 'medium' scan speed of 0.4 mm s −1
for the PDDs (non-equidistant sample sizes of 0.3-0.5 mm) and at a 'high' scan speed of 0.7 mm s −1 (non-equidistant sample sizes of 0.6-0.9 mm) for the beam profiles. Lower scan speeds were not used because the CZE-Mobetron R was positioned in an unmodified operating room, making it necessary to minimize the total number of MUs. Justified by the cylindrical symmetric design of the treatment head, only crossline profiles were measured to reduce the number of MUs even further. Before proceeding, both the measured PDDs and the beam profiles were post-processed. Here, the measured PDDs were re-sampled using a 2 mm running average filter. The measured beam profiles were first centered, then averaged about the central axis, and finally resampled using a 2 mm running average filter.
A quantitative comparison between the measured-and the MC simulated PDDs and beam profiles was performed by determining the γ -index as defined by Low et al (1998) . A relative dose of 2% and a distance-to-agreement of 1 mm were defined as the γ -acceptance criteria. To compare both data sets, first the measured PDDs were normalized to 100% at the maximum dose D max . Then, the MC simulated PDDs were normalized to match the measured PDDs best. This was done by minimizing the squared sum of the difference in relative dose per bin in the high-dose region. Both the measured-and the MC simulated single-sided beam profiles were normalized at the central axis region (first five bins) of the beam. In both cases, the measured PDD was used to determine the dose at the central axis region relative to D max .
Prototyping a 80 × 150 mm 2 rectangular applicator
In the second phase the resulting BEAMnrc model of the Mobetron R treatment head was used to design a 80 × 150 mm 2 rectangular applicator featuring an add-on applicator foil. Here, the scattering properties and resulting dose distributions of several foils of various materials and thickness were determined with simulation. This resulted in a final design consisting of a rectangular 0.4 mm thick Al plate covering the whole beam and a pyramid of four stacked cylindrical slabs of 0.5 mm thick Al of different diameters centered on top of it. This foil was mounted on top of a rectangular Al tube with a wall thickness of 10 mm to prevent radiation leakage through the walls.
A prototype was built (figure 3) and tested with diode dosimetry in a water tank. For the prototype a spacer was used to secure the applicator to the treatment head at a distance of 40 mm from the end of the primary collimator. The measured PDDs and beam profiles along the central axes were compared to the results of the MC predictions. Before doing so, small long-term drifts in the mean energy (0.1-0.3 MeV) were corrected for in the model. In between measurements the applicator was rotated 90
• so again only profiles along the crossline direction were considered. The post-processing, the matching of measured and MC data and the γ -analysis were performed as described in section 2.1.
For both the 100 mm applicator and the rectangular applicator the absolute output factors (OF) were determined from solid water phantom measurements with a Markus chamber at d max . Here, the measuring signal was corrected for the change in stopping-power ratio due to the energy degradation caused by the additional scattering foil. The found ratios for OF rect. app /OF 100 mm were then used to compare the measured output of the rectangular applicator to the MC predicted output.
To examine the clinical properties of the rectangular applicator, the measured PDDs and beam profiles at d max along the main axes of the applicator were analyzed. From the PDDs the following properties were determined: the relative surface dose (D s ), the depths of the 90% dose levels before (R 90,in ) and after (R 90 ) the maximum dose, the depth of the 50% dose level Finally, a set of crossline scans using 1 mm intervals in the inline direction were made to visualize the 2D dose distributions in one quadrant of the field at d max for 4 MeV, 6 MeV and 9 MeV.
Results

Monte Carlo modeling the Mobetron
R treatment head Figure 4 shows the measured and MC-simulated PDDs for a 100 mm applicator and a Mobetron R without an applicator. The beam profiles at 5 mm and at d max are shown in figure 5. The statistical uncertainty in the MC result is smaller than 0.3% (1 standard deviation) and is not indicated in the graphs. From the γ -indices that are represented graphically on top of the PDD graphs it is clear that only 2 out of the 280 analyzed bins (0.7%) fail the 2%/1 mm-criterion (γ > 1). Both failures represent 12 MeV data and the maximum found value for γ is 1.3 (12 MeV, no applicator). From the γ -indices that are represented graphically on top of the beam profile graphs it is clear that only 10 out of 720 analyzed bins (1.4%) fail the 2%/1 mm-criterion for 4 MeV, 6 MeV and 9 MeV. Here, the maximum found value for γ is 1.2 (6 MeV, z = 5 mm, no applicator). For the beam profiles at 12 MeV, 26 out of 240 analyzed bins (10.8%) fail the 2%/1 mm-criterion. Here, the maximum found value for γ is 1.8 (12 MeV, z = 5 mm, 100 mm applicator).
Prototyping an 80 × 150 mm 2 rectangular applicator
Figures 6 and 7 show the measured and MC-predicted PDDs and beam profiles at d max for the prototype 80 × 150 mm 2 rectangular applicator. To illustrate the loss in penetration depth and increased surface dose caused by the applicator foil, the measured PDDs for a 100 mm applicator are also shown in figure 6 . From the γ -indices shown on top of the PDD graphs it is clear that all of the 140 analyzed bins pass the 2%/1 mm-criterion (γ 1). From the γ -indices shown on top of the beam profile graphs it is clear that only 1 out of 288 analyzed bins (0.3%) fails the 2%/1 mm criterion for 6 MeV, 9 MeV and 12 MeV. Here, the maximum found value for γ is 1.1 (9 MeV, long side). For the beam profiles at 4 MeV only 3 out of 96 analyzed bins (3.1%) fail the 2%/1 mm-criterion. Here, the maximum found value for γ is 1.3 (4 MeV, long side).
The absolute output factor ratios OF rect. app /OF 100 mm comparing the rectangular applicator to the standard 100 mm applicator were 0.449, 0.538, 0.615 and 0.630 respectively for the four different energies. These deviate 1.0%, 0.6%, −2.5% and 0.2% respectively from the MC-calculated ratios.
The clinical properties of the rectangular applicator are summarized and compared to the clinical properties of a 100 mm applicator in table 1. Here, data for 12 MeV are omitted because the beam profiles along the long side of the applicator show too low a dose in the 'shoulders' (figure 7) to be of clinical use. Table 1 shows that (1) the low-energy electrons from the applicator foil improve the homogeneity of the dose distribution. This is expressed in an increase in surface dose D s of 8.1%, 5.6% and 4.7% for 4 MeV, 6 MeV and 9 MeV respectively. There is also a decrease in R 90,in of 2.2 mm, 3.9 mm and 1.5 mm for 4 MeV, 6 MeV and 9 MeV respectively. (2) The penetration depth is decreased due to energy loss R with the prototype rectangular 80 × 150 mm 2 applicator. Data for the short side (80 mm) and for the long side (150 mm) of the applicator are represented together in one plot using respectively the negative and positive x-axis. For the sake of clarity the profiles for 6 MeV, 9 MeV and 12 MeV are given an offset in a relative dose of 20%, 40% and 80% respectively). For each profile the γ -index (2%/1 mm) is also graphically represented.
when primary electrons traverse the additional Al scattering foil resulting in a decrease in R 90 of 1.4 mm, 1.3 mm and 3.7 mm and a decrease in R 50 of 1.4 mm, 1.5 mm and 3.1 mm for 4 MeV, 6 MeV and 9 MeV respectively. Still, a penetration depth (R 90 ) of 26 mm is achieved for the 9 MeV beam and the design criterion is met. (3) There is no significant increase of bremsstrahlung (D x ). (4) In both the long and the short side of the applicator the intended field size is achieved and (5) the beam flatness is comparable to the 100 mm applicator. (6) The penumbra of the rectangular applicator (long side) is less steep than the penumbra for a 100 mm applicator. However, the largest found value for d 90-50 is 7.2 mm for 9 MeV which is still acceptable. (7) Finally, the output of the rectangular applicator is lower than the output of a 100 mm applicator. Still, with output factors of 0.45 cGy MU −1 , 0.56 cGy MU −1 and 0.64 cGy MU −1 for 4 MeV, 6 MeV and 9 MeV respectively the design criterion is met. Finally, figure 8 shows the measured 50%, 90% and 95% isodose contours in one quadrant of the field at d max for 4 MeV, 6 MeV and 9 MeV.
Discussion
To our knowledge, this study is the first to present a Monte Carlo model for the Mobetron R and the first to present a Monte Carlo based design for an electron applicator using an additional scattering foil. However, the concept of using an additional scattering foil to increase dose homogeneity for IORT treatment fields has previously been reported by Björk et al (2000) . Table 1 . Clinical properties of the prototype rectangular 80 × 150 mm 2 applicator compared to those of the 100 mm applicator for 4 MeV, 6 MeV and 9 MeV. From the measured PDDs the following properties were determined: the relative surface dose (D s ), the depths of the 90% dose levels before (R 90,in ) and after (R 90 ) the maximum dose, the depth of the 50% dose level (R 50 To validate the Monte Carlo model of the treatment head we have compared both PDDs and beam profiles for a Mobetron R with a 100 mm applicator, a Mobetron R with a rectangular applicator and a Mobetron R without an applicator. We can conclude that the model agrees to the measurements for all PDDs (figures 4 and 6) with an accuracy of 2%/1 mm. The same can be said for the beam profiles (figures 5 and 7). For most of the points that exceed the γ -threshold this is likely to be caused by statistical fluctuation in the measured-and the calculated PDDs and beam profiles. A larger discrepancy between the model and the measurements is found in the beam profiles at 12 MeV for a 100 mm applicator and a Mobetron R without an applicator. This especially concerns the region near the edge of the high-dose region at z = 5 mm. Here, the maximum found value for γ is 1.8 due to a dose difference of 3.8%. The discrepancy may be due to a combination of inaccuracy in the source/geometry and other errors in the simulation such as radiation transport and experimental uncertainty. The discrepancy has a minimal impact on the outcome of the prototyping and was therefore not investigated further.
From the PDDs it becomes clear that our estimation of d max for the 100 mm applicator for 9 MeV and 12 MeV as well as our assumption that d max would be the same for the prototype rectangular applicator and the 100 mm applicator is somewhat off. However, for validation of the model this is not a problem and when we consider that the measured d max for the rectangular applicator is 7 mm, 11 mm and 15 mm for 4 MeV, 6 MeV and 9 MeV respectively we can conclude that profiles, determined at 9 mm, 13 mm and 19 mm respectively should represent the clinical properties of the beam close to the actual depth of the maximum dose. Based on the clinical properties in table 1, it can be concluded that the rectangular applicator meets the design criteria and based on the experience in this work it is estimated that extending the field size even further is feasible, at the cost of a further decrease in penetration and output and a possible increase of bremsstrahlung contamination. Depending on clinical requirements and frequency of application this could lead to useful other applicator designs. The isodose distributions shown in figure 8 look promising and show that it is possible to create a reasonably uniform, large rectangular field with a cylindrically symmetric treatment head of smaller size using a cylindrically symmetrical applicator scattering foil in a rectangular applicator. It may be possible to improve dose uniformity with different shapes of scattering foil and reduce bremsstrahlung contamination using a lower-Z material, even clear plastic or glass, with the potential for viewing the lesion through the foil.
Further changes are envisioned to translate the prototype into a clinical version: use of a stainless steel foil for thinner walls to allow smaller incisions, rounded edges to the applicator, and provision to access the applicator for visual verification of target alignment.
Summary and conclusions
A rectangular applicator capped with an Al scattering foil has been built and tested for use with the Mobetron R mobile IORT linac. Measurements showed rectangular 80 × 150 mm 2 field sizes with clinically acceptable dose distributions for 4 MeV, 6 MeV and 9 MeV. This obviates the use of complicated multiple irradiations with abutting field techniques. In addition, Monte Carlo simulation of the Mobetron R was able to predict dose distributions with an accuracy of 2%/1 mm in most cases. Monte Carlo simulation was very useful in designing the prototype, understanding the physics behind the measured differences in the dose distributions and output factors, and would be useful to model other potential applicator designs.
